GW791343 enhances ATP release rhythm amplitude in SCN cultures
Cell-based study · SCN organotypic cultures [1]
In SCN organotypic cultures, GW791343 was administered by replacing the medium with fresh drug-containing culture medium. Treatment enhanced ATP release rhythm amplitude and increased extracellular ATP accumulation relative to drug-free control cultures.
| Endpoint | Reported result | Reference |
|---|---|---|
| extracellular ATP accumulation | extracellular ATP accumulation 100 nM: 144 ± 6% of control levels | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 nM
- Exposure duration
- every 4 h; added at 8:00 h; over a 24–48 h incubation period
- Method
- completely replacing the medium with fresh drug-containing culture medium
- Reported limits
- Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: GW791343
The paper names GW791343 without stating the salt or form; not verified as the hydrochloride form supplied as A11107. No dose conversion or lot validation.
Materials and methods > Measurement of ATP production (S26, S27, S28); Results > Dependence of extracellular ATP accumulation on P2X7R activity (S80, S86)
extracellular ATP accumulation: extracellular ATP accumulation; comparator: fresh drug-free culture medium every 4 h — Results > Dependence of extracellular ATP accumulation on P2X7R activity (S86)